Published in Environ Microbiol on February 23, 2010
The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A (2012) 3.43
Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One (2010) 2.60
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J (2010) 2.55
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio (2010) 2.53
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol (2012) 2.50
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A (2012) 2.22
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One (2012) 2.03
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. PLoS One (2012) 1.80
The human microbiome and its potential importance to pediatrics. Pediatrics (2012) 1.74
Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med (2012) 1.64
The role of the bacterial microbiome in lung disease. Expert Rev Respir Med (2013) 1.62
Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One (2011) 1.61
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One (2013) 1.43
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med (2012) 1.40
Microbial communities of the upper respiratory tract and otitis media in children. MBio (2011) 1.38
Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis. J Clin Microbiol (2015) 1.29
An integrative approach to understanding microbial diversity: from intracellular mechanisms to community structure. Ecol Lett (2010) 1.21
Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol (2012) 1.17
The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med (2013) 1.14
In-depth characterization via complementing culture-independent approaches of the microbial community in an acidic hot spring of the Colombian Andes. Microb Ecol (2011) 1.10
Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol (2012) 1.10
Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa. ISME J (2011) 1.07
Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts. Proc Natl Acad Sci U S A (2013) 1.05
Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens. J Clin Microbiol (2011) 1.03
Pseudomonas aeruginosa biofilms in disease. Microb Ecol (2013) 1.02
Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infections. J Clin Microbiol (2014) 1.02
Modeling the impact of antibiotic exposure on human microbiota. Sci Rep (2014) 1.01
Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Ann Am Thorac Soc (2015) 1.00
Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions. PLoS One (2012) 1.00
Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep (2015) 0.99
Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax (2014) 0.98
Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS One (2013) 0.97
Interpreting infective microbiota: the importance of an ecological perspective. Trends Microbiol (2013) 0.96
Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections. Infect Immun (2011) 0.92
Transcriptional response of mucoid Pseudomonas aeruginosa to human respiratory mucus. MBio (2013) 0.92
The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome (2014) 0.91
Abundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiome. Appl Environ Microbiol (2013) 0.90
Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis. J Pediatr (2015) 0.90
Porphyromonas gingivalis: keeping the pathos out of the biont. J Oral Microbiol (2013) 0.89
The Microbiome in Cystic Fibrosis. Clin Chest Med (2015) 0.89
The microbial community of the cystic fibrosis airway is disrupted in early life. PLoS One (2014) 0.86
Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencing. PLoS One (2014) 0.86
Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease. PLoS One (2016) 0.84
High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment. PLoS One (2015) 0.84
Polymicrobial airway bacterial communities in adult bronchiectasis patients. BMC Microbiol (2014) 0.83
Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention. ISME J (2015) 0.83
Why the human microbiome project should motivate epidemiologists to learn ecology. Epidemiology (2010) 0.82
Draft Genome Sequences of Seven Pseudomonas fluorescens Subclade III Strains Isolated from Cystic Fibrosis Patients. Genome Announc (2015) 0.81
Respiratory tract clinical sample selection for microbiota analysis in patients with pulmonary tuberculosis. Microbiome (2014) 0.80
Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease. PLoS Pathog (2016) 0.80
Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens. J Clin Microbiol (2015) 0.79
Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes. Eur J Clin Microbiol Infect Dis (2016) 0.77
Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization. Springerplus (2015) 0.77
In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa. Antimicrob Agents Chemother (2015) 0.76
The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol (2016) 0.76
Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns. PLoS One (2015) 0.76
The effects of inhaled aztreonam on the cystic fibrosis lung microbiome. Microbiome (2017) 0.76
Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice. Postgrad Med J (2015) 0.75
The Dynamics of Disease Progression in Cystic Fibrosis. PLoS One (2016) 0.75
Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa. PLoS One (2017) 0.75
Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients. Mol Cell Pediatr (2017) 0.75
Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis. PLoS One (2016) 0.75
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? Curr Opin Pulm Med (2017) 0.75
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Microbial biogeography: putting microorganisms on the map. Nat Rev Microbiol (2006) 14.24
Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature (2002) 9.07
Phylocom: software for the analysis of phylogenetic community structure and trait evolution. Bioinformatics (2008) 7.91
A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science (2006) 7.84
Biofilms: the matrix revisited. Trends Microbiol (2005) 6.66
Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 6.10
The merging of community ecology and phylogenetic biology. Ecol Lett (2009) 5.98
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene (2004) 5.79
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science (2006) 5.41
A taxa-area relationship for bacteria. Nature (2004) 5.36
Species abundance distributions: moving beyond single prediction theories to integration within an ecological framework. Ecol Lett (2007) 5.29
A major protein component of the Bacillus subtilis biofilm matrix. Mol Microbiol (2006) 5.09
A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell (2004) 4.98
Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol Microbiol (2004) 4.97
High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol (2007) 4.81
The application of ecological theory toward an understanding of the human microbiome. Science (2012) 4.69
Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol (2012) 4.68
The role of ecological theory in microbial ecology. Nat Rev Microbiol (2007) 4.50
A master regulator for biofilm formation by Bacillus subtilis. Mol Microbiol (2005) 4.44
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence. Proc Natl Acad Sci U S A (2006) 4.33
Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2003) 4.07
A latitudinal diversity gradient in planktonic marine bacteria. Proc Natl Acad Sci U S A (2008) 4.00
Spatial scaling of microbial biodiversity. Trends Ecol Evol (2006) 3.95
Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J Bacteriol (2004) 3.92
Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev (2008) 3.92
Bistability and biofilm formation in Bacillus subtilis. Mol Microbiol (2007) 3.83
Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc Natl Acad Sci U S A (2010) 3.78
Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev Cell (2003) 3.72
Colloquium paper: microbes on mountainsides: contrasting elevational patterns of bacterial and plant diversity. Proc Natl Acad Sci U S A (2008) 3.71
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
D-amino acids trigger biofilm disassembly. Science (2010) 3.60
A cyclic-di-GMP receptor required for bacterial exopolysaccharide production. Mol Microbiol (2007) 3.54
Microbial sciences: the superficial life of microbes. Nature (2006) 3.45
Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A (2008) 3.45
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One (2010) 3.38
Pseudomonas-Candida interactions: an ecological role for virulence factors. Science (2002) 3.35
Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc Natl Acad Sci U S A (2005) 3.31
Microbial biogeography: from taxonomy to traits. Science (2008) 3.22
Targets of the master regulator of biofilm formation in Bacillus subtilis. Mol Microbiol (2006) 3.21
An ecological perspective on bacterial biodiversity. Proc Biol Sci (2004) 3.13
The second messenger bis-(3'-5')-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol Microbiol (2007) 3.11
Biofilms. Cold Spring Harb Perspect Biol (2010) 3.10
A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol (2004) 3.05
A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol (2003) 3.05
Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A (2010) 3.05
On estimating the exponent of power-law frequency distributions. Ecology (2008) 2.95
Genes involved in formation of structured multicellular communities by Bacillus subtilis. J Bacteriol (2004) 2.86
A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes. Mol Microbiol (2005) 2.71
Sticking together: building a biofilm the Bacillus subtilis way. Nat Rev Microbiol (2013) 2.68
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64
Generation of multiple cell types in Bacillus subtilis. FEMS Microbiol Rev (2008) 2.63
Big questions, small worlds: microbial model systems in ecology. Trends Ecol Evol (2004) 2.61
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Into the eye of the cytokine storm. Microbiol Mol Biol Rev (2012) 2.58
Local migration promotes competitive restraint in a host-pathogen 'tragedy of the commons'. Nature (2006) 2.58
PhylOTU: a high-throughput procedure quantifies microbial community diversity and resolves novel taxa from metagenomic data. PLoS Comput Biol (2011) 2.54
Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis. Proc Natl Acad Sci U S A (2008) 2.54
Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio (2010) 2.53
Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun (2005) 2.51
Incorporating 16S gene copy number information improves estimates of microbial diversity and abundance. PLoS Comput Biol (2012) 2.50
Functional microdomains in bacterial membranes. Genes Dev (2010) 2.50
Thinking about Bacillus subtilis as a multicellular organism. Curr Opin Microbiol (2007) 2.48
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47
Cryptic population dynamics: rapid evolution masks trophic interactions. PLoS Biol (2007) 2.44
Bacterial diversity and White Plague Disease-associated community changes in the Caribbean coral Montastraea faveolata. ISME J (2009) 2.44
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS (2010) 2.42
Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol (2010) 2.41
Architectural design influences the diversity and structure of the built environment microbiome. ISME J (2012) 2.36
Phylogenetic clustering and overdispersion in bacterial communities. Ecology (2006) 2.35
Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J (2010) 2.33
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A (2002) 2.24
Environmental whole-genome amplification to access microbial populations in contaminated sediments. Appl Environ Microbiol (2006) 2.24
Marine diatom species harbour distinct bacterial communities. Environ Microbiol (2005) 2.22
Facile detection of acyl and peptidyl intermediates on thiotemplate carrier domains via phosphopantetheinyl elimination reactions during tandem mass spectrometry. Biochemistry (2006) 2.22
Ecology and genomics of Bacillus subtilis. Trends Microbiol (2008) 2.22
The identification of bacillaene, the product of the PksX megacomplex in Bacillus subtilis. Proc Natl Acad Sci U S A (2007) 2.22
Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA. Mol Microbiol (2009) 2.19
Identification and characterization of a Vibrio cholerae gene, mbaA, involved in maintenance of biofilm architecture. J Bacteriol (2003) 2.18
Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest (2009) 2.17
An accessory protein required for anchoring and assembly of amyloid fibres in B. subtilis biofilms. Mol Microbiol (2011) 2.17
Essential role of MMP-12 in Fas-induced lung fibrosis. Am J Respir Cell Mol Biol (2007) 2.16
The Jekyll-and-Hyde chemistry of Phaeobacter gallaeciensis. Nat Chem (2011) 2.12
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol (2010) 2.11